Treosulfan is an alkylating agent used as a conditioning treatment prior to allogeneic hematopoietic stem cell transplantation. It clears the bone marrow to make room for transplanted donor cells, and is administered together with fludarabine in both adults and children from one month of age with blood cancers or other severe disorders requiring a transplant.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 299-75-2
Sodium lauroyl glutamate
surfactant for personal care and cosmetics
Trimethoxyphenylsilane
chemical intermediate and surface treatment agent
3-phenylnaphthalen-1-ol
Research compound
N-(4-acetyl-3-hydroxy-2-nitrophenyl)acetamide
research compound
The international HS code for Treosulfan (CAS 299-75-2) is 2905.49.
2905.49
2905 49 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(2S,3S)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate
YCPOZVAOBBQLRI-WDSKDSINSA-N
CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O